OverviewSuggest Edit

Cotiviti (formed as a result of the merger of Verscend Technologies and Cotiviti Holdings) provides analytics-driven payment accuracy solutions primarily for the healthcare sector. The company operates through two segments: Healthcare and Global Retail and Other. Cotiviti offers prospective claims accuracy solutions that enable healthcare clients to identify and address claim discrepancies immediately following claim adjudication and before a claim is paid to a healthcare provider, and retrospective claims accuracy solutions that enable health insurers to identify and resolve payment inaccuracies after a claim has been paid to a healthcare provider. The company also provides analytics and support services, including anti-fraud, waste and abuse analytics to identify abnormal patterns in coding and billing practices; surveillance and longitudinal analytics.

HQAtlanta, US
Employee Ratings3
Overall CultureF

Latest Updates

Employees (est.) (Nov 2020)3,278
Revenue (FY, 2017)$678.7 M(+9%)
Share Price (Aug 2018)$44.7
Cybersecurity ratingCMore

Key People/Management at Cotiviti

Emad Rizk

Emad Rizk

President and Chief Executive Officer
Chris Coloian

Chris Coloian

Executive Vice President, Revenue and Growth
Kerri Eskin

Kerri Eskin

Executive Vice President, Human Resources
Joe Morrissey

Joe Morrissey

Executive Vice President, Client Engagement
Richard Pozen

Richard Pozen

Chief Medical Officer
Show more

Cotiviti Office Locations

Cotiviti has offices in Atlanta and Waltham
Atlanta, US (HQ)
1 Glenlake Pkwy NE
Waltham, US
201 Jones Rd 4th Floor
Show all (2)

Cotiviti Financials and Metrics

Summary Metrics

Founding Date

Show all financial metrics

Cotiviti Revenue

Embed Graph
View revenue for all periods
Cotiviti's revenue was reported to be $678.66 m in FY, 2017 which is a 8.6% increase from the previous period.

Revenue (Q2, 2018)


Gross profit (Q2, 2018)


Gross profit margin (Q2, 2018), %


Net income (Q2, 2018)


EBIT (Q2, 2018)


Cash (30-Jun-2018)

USDFY, 2015FY, 2016FY, 2017



Revenue growth, %


Cost of goods sold


Gross profit

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018



Cost of goods sold


Gross profit


Gross profit Margin, %

USDFY, 2015FY, 2016FY, 2017



Accounts Receivable


Prepaid Expenses


Current Assets

USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018



Accounts Receivable


Prepaid Expenses


Current Assets

USDFY, 2015FY, 2016FY, 2017

Net Income


Depreciation and Amortization


Accounts Payable


Cash From Operating Activities

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income


Depreciation and Amortization


Accounts Payable


Cash From Operating Activities

USDFY, 2015


1.3 x


0.5 x

Financial Leverage

2.7 x
Show all financial metrics

Cotiviti Operating Metrics

FY, 2016FY, 2017

Customer Savings

$500 m$550 m

Facilities Leased (International)

6 5

Facilities Leased (US)

19 21

Retail Customers

35 30
Show all operating metrics

Cotiviti Acquisitions / Subsidiaries

Company NameDateDeal Size
RowdMap, Inc.July 10, 2017$100 m
Cotiviti Canada Corp.
Cotiviti Corporation
Cotiviti Domestic Holdings, Inc.
Cotiviti Europe Limited (UK)
Cotiviti India Pvt. Ltd.
Cotiviti Intermediate Holdings, Inc.
Cotiviti International Holdings, Inc.
Cotiviti Investments, LLC
Cotiviti, LLC
Show more

Cotiviti Revenue Breakdown

Embed Graph

Cotiviti revenue breakdown by business segment: 89.2% from Healthcare and 10.8% from Global Retail and Other

Cotiviti Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Cotiviti Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset


out of 100

CSRHub logo

Cotiviti Online and Social Media Presence

Embed Graph

Cotiviti Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



  • Diversity



Learn more on Comparably

Cotiviti News and Updates

COTIVITI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cotiviti Holdings, Inc.

NEW ORLEANS, June 20, 2018 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cotiviti Holdings, Inc. ("Cotiviti") (NYSE: COTV) to Verscend Technologies, Inc. Under...

WeissLaw LLP Investigates Cotiviti Holdings, Inc. Acquisition

NEW YORK, June 19, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Cotiviti Holdings, Inc. ("COTV" or the "Company") (NYSE: COTV) in connection with the proposed acquisition of the Company by...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cotiviti Holdings, Inc.

NEW YORK, June 19, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Cotiviti Holdings, Inc. (NYSE: COTV) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Veritas Capital. Stockholders will receive...

Cotiviti Blogs

Podcast: Dr. Emad Rizk on managing telehealth concerns amid COVID-19

The extraordinary increase in telehealth usage during the COVID-19 pandemic has opened the door for potential healthcare fraud, waste, and abuse (FWA), particularly around upcoding. Cotiviti CEO Emad Rizk, M.D., recently appeared on the Healthcare Financial Management Association’s (HFMA…

Precision medicine’s value to complex disease management

Understanding how individuals vary on disease susceptibility is becoming increasingly important for clinicians to deliver effective treatment to their patients. For example, some patients are fortunate to survive cancer multiple times, while others die within a few months of their diagno…

Case study: Identifying potential fraud, waste, and abuse during the COVID-19 pandemic

While the COVID-19 pandemic has challenged providers in significant ways, it unfortunately has also created new opportunities for a small handful of bad actors to take advantage of the outbreak to increase their reimbursement. Here’s how Cotiviti recently worked with MetroPlus Health Pla…

Cotiviti clients outperform the field in 2021 Star Ratings

With Medicare open enrollment set to begin this week, the Centers for Medicare & Medicaid Services (CMS) has released the 2021 Star Ratings for Medicare Advantage plans with prescription drug coverage (MA-PD) as well as standalone MA and PD plans, based on data from calendar year 201…

Dr. Emad Rizk: why analytics-driven interoperability is vital in 2020 and beyond

Provider access to medical history is crucial for patients diagnosed with COVID-19, which often leads to worse outcomes for those with significant comorbidities. But due to lack of interoperability between healthcare IT systems, patient history can be cumbersome to obtain—and this can ha…

Case study: Accelerating value-driven care through provider specialty tiering

Leading health plans know that to stay competitive and meet the demands of the members and employer groups they serve, they must proactively increase the value of care they provide while decreasing costs. That’s why one major health plan in North Carolina, serving nearly 4 million member…
Show more

Cotiviti Frequently Asked Questions

  • When was Cotiviti founded?

    Cotiviti was founded in 1979.

  • Who are Cotiviti key executives?

    Cotiviti's key executives are Emad Rizk, Chris Coloian and Kerri Eskin.

  • How many employees does Cotiviti have?

    Cotiviti has 3,278 employees.

  • What is Cotiviti revenue?

    Latest Cotiviti annual revenue is $678.7 m.

  • What is Cotiviti revenue per employee?

    Latest Cotiviti revenue per employee is $207 k.

  • Who are Cotiviti competitors?

    Competitors of Cotiviti include Greenphire, Eligible and ECHO Health.

  • Where is Cotiviti headquarters?

    Cotiviti headquarters is located at 1 Glenlake Pkwy NE, Atlanta.

  • Where are Cotiviti offices?

    Cotiviti has offices in Atlanta and Waltham.

  • How many offices does Cotiviti have?

    Cotiviti has 2 offices.